These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 18372573

  • 1. QT and TdP. QT: an unreliable predictor of proarrhythmia.
    Hondeghem LM.
    Acta Cardiol; 2008 Feb; 63(1):1-7. PubMed ID: 18372573
    [Abstract] [Full Text] [Related]

  • 2. TRIad: foundation for proarrhythmia (triangulation, reverse use dependence and instability).
    Hondeghem LM.
    Novartis Found Symp; 2005 Feb; 266():235-44; discussion 244-50. PubMed ID: 16050272
    [Abstract] [Full Text] [Related]

  • 3. Thorough QT/QTc not so thorough: removes torsadogenic predictors from the T-wave, incriminates safe drugs, and misses profibrillatory drugs.
    Hondeghem LM.
    J Cardiovasc Electrophysiol; 2006 Mar; 17(3):337-40. PubMed ID: 16643415
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
    Lu HR, Yan GX, Gallacher DJ.
    J Pharmacol Toxicol Methods; 2013 Mar; 68(2):250-259. PubMed ID: 23337247
    [Abstract] [Full Text] [Related]

  • 6. Refining detection of drug-induced proarrhythmia: QT interval and TRIaD.
    Shah RR, Hondeghem LM.
    Heart Rhythm; 2005 Jul; 2(7):758-72. PubMed ID: 15992736
    [Abstract] [Full Text] [Related]

  • 7. Beat-by-beat QT interval variability, but not QT prolongation per se, predicts drug-induced torsades de pointes in the anaesthetised methoxamine-sensitized rabbit.
    Jacobson I, Carlsson L, Duker G.
    J Pharmacol Toxicol Methods; 2011 Jul; 63(1):40-6. PubMed ID: 20451633
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Drug-Induced QT Prolongation and Torsades de Pointes: An All-Exclusive Relationship or Time for an Amicable Separation?
    Hondeghem LM.
    Drug Saf; 2018 Jan; 41(1):11-17. PubMed ID: 28853038
    [Abstract] [Full Text] [Related]

  • 11. Nonclinical proarrhythmia models: predicting Torsades de Pointes.
    Lawrence CL, Pollard CE, Hammond TG, Valentin JP.
    J Pharmacol Toxicol Methods; 2005 Jan; 52(1):46-59. PubMed ID: 15975832
    [Abstract] [Full Text] [Related]

  • 12. Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.
    Milberg P, Eckardt L, Bruns HJ, Biertz J, Ramtin S, Reinsch N, Fleischer D, Kirchhof P, Fabritz L, Breithardt G, Haverkamp W.
    J Pharmacol Exp Ther; 2002 Oct; 303(1):218-25. PubMed ID: 12235254
    [Abstract] [Full Text] [Related]

  • 13. Instability and triangulation of the action potential predict serious proarrhythmia, but action potential duration prolongation is antiarrhythmic.
    Hondeghem LM, Carlsson L, Duker G.
    Circulation; 2001 Apr 17; 103(15):2004-13. PubMed ID: 11306531
    [Abstract] [Full Text] [Related]

  • 14. Transmural dispersion of repolarization as a preclinical marker of drug-induced proarrhythmia.
    Said TH, Wilson LD, Jeyaraj D, Fossa AA, Rosenbaum DS.
    J Cardiovasc Pharmacol; 2012 Aug 17; 60(2):165-71. PubMed ID: 22561361
    [Abstract] [Full Text] [Related]

  • 15. Antiarrhythmic effect of antazoline in experimental models of acquired short- and long-QT-syndromes.
    Ellermann C, Sterneberg M, Kochhäuser S, Dechering DG, Fehr M, Eckardt L, Frommeyer G.
    Europace; 2018 Oct 01; 20(10):1699-1706. PubMed ID: 29377987
    [Abstract] [Full Text] [Related]

  • 16. QT prolongation and torsade de pointes induced by fluoroquinolones: infrequent side effects from commonly used medications.
    Briasoulis A, Agarwal V, Pierce WJ.
    Cardiology; 2011 Oct 01; 120(2):103-10. PubMed ID: 22156660
    [Abstract] [Full Text] [Related]

  • 17. Drug-induced QT prolongation and proarrhythmia: an inevitable link?
    Ahmad K, Dorian P.
    Europace; 2007 Sep 01; 9 Suppl 4():iv16-22. PubMed ID: 17766320
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Lengthening of QT interval by antipsychotic drugs].
    Haverkamp W, Deuschle M.
    Nervenarzt; 2006 Mar 01; 77(3):276, 278-80, 282-4 passim. PubMed ID: 16052325
    [Abstract] [Full Text] [Related]

  • 20. A new preclinical biomarker for risk of Torsades de Pointes: drug-induced reduction of the cardiac electromechanical window.
    Vargas HM.
    Br J Pharmacol; 2010 Dec 01; 161(7):1441-3. PubMed ID: 20698854
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.